These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6330605

  • 21. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ, Domino EF.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):306-11. PubMed ID: 6092613
    [Abstract] [Full Text] [Related]

  • 22. Convulsions may alter the specificity of kappa-opiate receptors.
    Mansour A, Valenstein ES.
    Exp Neurol; 1986 Jun; 92(3):571-82. PubMed ID: 3011487
    [Abstract] [Full Text] [Related]

  • 23. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M, Kubota A, Iwama T, Wada T, Yasui M, Fujibayashi K, Takagi H.
    Life Sci; 1983 Jun; 33 Suppl 1():689-92. PubMed ID: 6141508
    [Abstract] [Full Text] [Related]

  • 24. Effects of ketocyclazocine and ethylketocyclazocine on electric shock titration.
    Dykstra LA.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):19-26. PubMed ID: 6360694
    [Abstract] [Full Text] [Related]

  • 25. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Mar 14; 252(3):945-52. PubMed ID: 1969478
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. EEG and behavioral effects of ethylketocyclazocine, morphine and cyclazocine in rats: differential sensitivities towards naloxone.
    Tortella FC, Cowan A, Adler MW.
    Neuropharmacology; 1980 Sep 14; 19(9):845-50. PubMed ID: 6106909
    [No Abstract] [Full Text] [Related]

  • 28. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM.
    J Pharmacol Exp Ther; 1985 Jun 14; 233(3):863-9. PubMed ID: 2989500
    [Abstract] [Full Text] [Related]

  • 29. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S, Kim HS, Wood PL.
    J Pharmacol Exp Ther; 1986 Aug 14; 238(2):429-36. PubMed ID: 3016237
    [Abstract] [Full Text] [Related]

  • 30. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM, Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May 14; 249(2):386-93. PubMed ID: 2542528
    [Abstract] [Full Text] [Related]

  • 31. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW, Gorney B, Cornfeldt M, Fielding S.
    Psychopharmacology (Berl); 1989 May 14; 99(4):492-6. PubMed ID: 2556726
    [Abstract] [Full Text] [Related]

  • 32. Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine.
    Hynes MD, Hymson DL.
    Eur J Pharmacol; 1984 Oct 01; 105(1-2):155-9. PubMed ID: 6149142
    [Abstract] [Full Text] [Related]

  • 33. Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power.
    Stamidis H, Young GA.
    Peptides; 1992 Oct 01; 13(4):755-60. PubMed ID: 1331999
    [Abstract] [Full Text] [Related]

  • 34. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
    Khazan N, Young GA, Calligaro D.
    Life Sci; 1983 Oct 01; 33 Suppl 1():559-62. PubMed ID: 6319910
    [Abstract] [Full Text] [Related]

  • 35. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL, Richard JW, Thakur M.
    Life Sci; 1983 Oct 01; 31(20-21):2313-7. PubMed ID: 6131359
    [Abstract] [Full Text] [Related]

  • 36. A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat.
    Porreca F, Raffa RB, Cowan A, Tallarida RJ.
    Life Sci; 1982 Nov 01; 31(18):1955-61. PubMed ID: 6294424
    [Abstract] [Full Text] [Related]

  • 37. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 01; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 38. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC, Moreton JE, Khazan N.
    J Pharmacol Exp Ther; 1979 Aug 01; 210(2):174-9. PubMed ID: 222892
    [Abstract] [Full Text] [Related]

  • 39. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1987 Oct 01; 243(1):234-40. PubMed ID: 2822899
    [Abstract] [Full Text] [Related]

  • 40. A kappa opioid effect: increased urination in the rat.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Jan 01; 224(1):89-94. PubMed ID: 6294284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.